A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT07030517 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07030517
- Sponsor
- Johnson & Johnson Private Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-22
- Primary completion
- 2026-11-03
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.